Shanghai Chemspec Corporation (SHA:688602)
China · Delayed Price · Currency is CNY 7.90
-0.11 (-1.37%)
Apr 28, 2026, 4:00 PM EDT
Shanghai Chemspec Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 678.26 | 771.56 | 653.13 | 951.48 | 1,209 | 967.07 |
Other Revenue | - | - | 21.68 | 28.11 | 28.83 | 37.56 |
| 678.26 | 771.56 | 674.81 | 979.59 | 1,238 | 1,005 | |
Revenue Growth (YoY) | -9.50% | 14.34% | -31.11% | -20.89% | 23.25% | 59.67% |
Cost of Revenue | 803.88 | 851.42 | 629.76 | 723.74 | 885.37 | 667.06 |
Gross Profit | -125.62 | -79.86 | 45.06 | 255.85 | 352.83 | 337.57 |
Selling, General & Admin | 4.06 | - | 98.24 | 95.33 | 98.17 | 83.48 |
Research & Development | 0.51 | - | 85.39 | 86.86 | 86.78 | 74.96 |
Other Operating Expenses | 2.33 | - | 2.43 | 5.82 | 8.03 | 8.7 |
Operating Expenses | 6.89 | - | 189.65 | 186.44 | 191.31 | 167.61 |
Operating Income | -132.51 | -79.86 | -144.59 | 69.41 | 161.52 | 169.97 |
Interest Expense | - | - | -7.4 | -9.08 | -6.93 | -9.05 |
Interest & Investment Income | - | - | 63.12 | 18.01 | 1.37 | 20.92 |
Earnings From Equity Investments | 3.33 | - | - | - | 29.72 | - |
Currency Exchange Gain (Loss) | - | - | 5.03 | 4.75 | -0.14 | -1.91 |
Other Non Operating Income (Expenses) | -4.81 | 2.44 | -0.14 | -0.65 | -0.83 | -0.54 |
EBT Excluding Unusual Items | -134 | -77.42 | -83.99 | 82.44 | 184.7 | 179.38 |
Gain (Loss) on Sale of Investments | 2.23 | - | 8.78 | 4.73 | 4.44 | -41.15 |
Gain (Loss) on Sale of Assets | 0.04 | - | -0.71 | 25.62 | -2.48 | -0.13 |
Asset Writedown | 2.78 | - | - | - | - | -2.72 |
Other Unusual Items | - | - | 4.11 | 13.02 | 13.81 | 10.16 |
Pretax Income | -128.94 | -77.42 | -71.81 | 125.81 | 200.48 | 147.04 |
Income Tax Expense | -26.36 | -16.87 | -21.15 | 10.68 | 17.79 | 8.75 |
Earnings From Continuing Operations | -102.59 | -60.55 | -50.66 | 115.13 | 182.68 | 138.29 |
Minority Interest in Earnings | -1.17 | - | 1.12 | -2.43 | -2.12 | -4.22 |
Net Income | -103.76 | -60.55 | -49.53 | 112.7 | 180.56 | 134.07 |
Net Income to Common | -103.76 | -60.55 | -49.53 | 112.7 | 180.56 | 134.07 |
Net Income Growth | - | - | - | -37.59% | 34.68% | 48.51% |
Shares Outstanding (Basic) | 534 | 505 | 495 | 451 | 420 | 388 |
Shares Outstanding (Diluted) | 534 | 505 | 495 | 451 | 420 | 388 |
Shares Change (YoY) | 6.19% | 1.86% | 9.88% | 7.35% | 8.29% | 7.71% |
EPS (Basic) | -0.19 | -0.12 | -0.10 | 0.25 | 0.43 | 0.35 |
EPS (Diluted) | -0.19 | -0.12 | -0.10 | 0.25 | 0.43 | 0.35 |
EPS Growth | - | - | - | -41.86% | 24.37% | 38.30% |
Free Cash Flow | - | - | -100.83 | 81.41 | 13.19 | -76.08 |
Free Cash Flow Per Share | - | - | -0.20 | 0.18 | 0.03 | -0.20 |
Dividend Per Share | - | - | - | 0.066 | - | - |
Gross Margin | -18.52% | -10.35% | 6.68% | 26.12% | 28.49% | 33.60% |
Operating Margin | -19.54% | -10.35% | -21.43% | 7.09% | 13.04% | 16.92% |
Profit Margin | -15.30% | -7.85% | -7.34% | 11.51% | 14.58% | 13.35% |
Free Cash Flow Margin | - | - | -14.94% | 8.31% | 1.06% | -7.57% |
EBITDA | - | 73.43 | 8.7 | 195.99 | 283.08 | 265.28 |
EBITDA Margin | - | 9.52% | 1.29% | 20.01% | 22.86% | 26.41% |
D&A For EBITDA | - | 153.29 | 153.29 | 126.58 | 121.57 | 95.31 |
EBIT | -132.51 | -79.86 | -144.59 | 69.41 | 161.52 | 169.97 |
EBIT Margin | -19.54% | -10.35% | -21.43% | 7.09% | 13.04% | 16.92% |
Effective Tax Rate | - | - | - | 8.49% | 8.88% | 5.95% |
Revenue as Reported | - | - | 674.81 | 979.59 | 1,238 | - |
Advertising Expenses | - | - | 0.65 | 0.67 | 0.11 | 0.39 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.